Last 12 months
Inside the activity.
0 purchase rows · 34 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2019 Filed Jun 12, 2019 20:07 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,750 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-19-001408 · primary_01.xml · derivative · entry 6 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,375 Underlying: Common Stock · 8,750 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 20:07 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,750 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001593968-19-001408 · primary_01.xml · derivative · entry 5 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,769 Underlying: Common Stock · 8,750 shares Expires 2025-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 180,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 20:07 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 8,750 | $15.53 | $135,863.00 |
DisclosureSEC source: 0001593968-19-001408 · primary_01.xml · nonDerivative · entry 4 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,672 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 20:07 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 8,750 | $15.72 | $137,509.75 |
DisclosureSEC source: 0001593968-19-001408 · primary_01.xml · nonDerivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,422 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 20:07 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 8,750 | $3.02 | $26,425.00 |
DisclosureSEC source: 0001593968-19-001408 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 20:07 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 8,750 | $2.75 | $24,062.50 |
DisclosureSEC source: 0001593968-19-001408 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2019 Filed May 14, 2019 20:23 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-19-001094 · primary_01.xml · derivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,125 Underlying: Common Stock · 17,500 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. Read SEC document |
| May 13, 2019 Filed May 14, 2019 20:23 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 17,500 | $17.02 | $297,858.75 |
DisclosureSEC source: 0001593968-19-001094 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,672 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| May 13, 2019 Filed May 14, 2019 20:23 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 17,500 | $2.75 | $48,125.00 |
DisclosureSEC source: 0001593968-19-001094 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:10 UTC |
Rubino Alan LDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-001038 · primary_01.xml · derivative · entry 2 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:10 UTC |
Rubino Alan LDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001593968-19-001038 · primary_01.xml · derivative · entry 1 Rubino Alan L · CIK 0001340228 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2029-05-01 F1 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:09 UTC |
MCLAUGHLIN KEVIN FDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-001037 · primary_01.xml · derivative · entry 2 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:09 UTC |
MCLAUGHLIN KEVIN FDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001593968-19-001037 · primary_01.xml · derivative · entry 1 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2029-05-01 F1 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:07 UTC |
GILMAN STEVEN CDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-001035 · primary_01.xml · derivative · entry 5 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F5 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. F6 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:07 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001593968-19-001035 · primary_01.xml · derivative · entry 4 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2029-05-01 F3 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:07 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001593968-19-001035 · primary_01.xml · derivative · entry 3 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 15,000 shares, became exercisable in equal monthly installments, contingent upon continued service to the Company, with the first vesting date on June 4, 2016, which was one month after the date on which the option was granted. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:07 UTC |
GILMAN STEVEN CDirector
|
SaleCommon Stock | 7,500 | $16.81 | $126,094.50 |
DisclosureSEC source: 0001593968-19-001035 · primary_01.xml · nonDerivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:07 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionCommon Stock | 7,500 | $2.76 | $20,700.00 |
DisclosureSEC source: 0001593968-19-001035 · primary_01.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:08 UTC |
Hagen HeidiDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001593968-19-001036 · primary_01.xml · derivative · entry 2 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2029-05-01 F4 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:08 UTC |
Hagen HeidiDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-001036 · primary_01.xml · derivative · entry 1 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F2 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. F3 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:04 UTC |
Wotton Paul KDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-001034 · primary_01.xml · derivative · entry 2 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:04 UTC |
Wotton Paul KDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001593968-19-001034 · primary_01.xml · derivative · entry 1 Wotton Paul K · CIK 0001300997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2029-05-01 F1 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:03 UTC |
ZERBE ROBERT L MDDirector
|
GrantRestricted Stock Unit · Derivative | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-001033 · primary_01.xml · derivative · entry 2 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,750 Underlying: Common Stock · 1,750 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest 100% on the earlier of May 1, 2020 or the date of the first Annual Meeting of Stockholders following May 1, 2019. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| May 01, 2019 Filed May 3, 2019 20:03 UTC |
ZERBE ROBERT L MDDirector
|
GrantStock Option (right to buy) · Derivative | 13,125 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001593968-19-001033 · primary_01.xml · derivative · entry 1 ZERBE ROBERT L MD · CIK 0001220363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,125 Underlying: Common Stock · 13,125 shares Expires 2029-05-01 F1 · derivative.exercise_date: The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,875 | $0.00 Strike: $7.20 | $0.00 |
DisclosureSEC source: 0001593968-19-000947 · primary_01.xml · derivative · entry 9 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,125 Underlying: Common Stock · 1,875 shares Expires 2028-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options, representing the right to purchase a total of 100,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 7, 2018, which was one quarter after the date on which the option was granted. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 9,375 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001593968-19-000947 · primary_01.xml · derivative · entry 8 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 9,375 shares Expires 2027-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 6.25% of these options, representing the right to purchase a total of 30,000 shares, became exercisable immediately on May 22, 2017. An additional 6.25% became exercisable on August 8, 2017 and continue to vest in equal quarterly installments from August 8, 2017, contingent upon the continued service to the Company. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,375 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001593968-19-000947 · primary_01.xml · derivative · entry 7 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,625 Underlying: Common Stock · 4,375 shares Expires 2027-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 70,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 8, 2017, which was one quarter after the date on which the option was granted. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 1,875 | $17.74 | $33,267.75 |
DisclosureSEC source: 0001593968-19-000947 · primary_01.xml · nonDerivative · entry 6 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,672 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 1,875 | $7.20 | $13,500.00 |
DisclosureSEC source: 0001593968-19-000947 · primary_01.xml · nonDerivative · entry 5 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 9,375 | $17.74 | $166,338.75 |
DisclosureSEC source: 0001593968-19-000947 · primary_01.xml · nonDerivative · entry 4 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,672 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 9,375 | $2.65 | $24,843.75 |
DisclosureSEC source: 0001593968-19-000947 · primary_01.xml · nonDerivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 4,375 | $17.37 | $75,985.44 |
DisclosureSEC source: 0001593968-19-000947 · primary_01.xml · nonDerivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,672 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
Exercise / conversionCommon Stock | 4,375 | $2.75 | $12,031.25 |
DisclosureSEC source: 0001593968-19-000947 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2019 Filed Feb 11, 2020 21:41 UTC |
Orlando DanielChief Operating Officer
|
GrantCommon Stock | 282 | $14.79 | $4,170.78 |
DisclosureSEC source: 0001593968-20-000398 · primary_01.xml · nonDerivative · entry 1 Orlando Daniel · CIK 0001563759 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,960 F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| March 11, 2019 Filed Mar 12, 2019 20:12 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 10,000 | $20.02 | $200,235.00 |
DisclosureSEC source: 0001593968-19-000766 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,249 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 21:01 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001593968-19-000610 · primary_01.xml · derivative · entry 3 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 15,000 shares, became exercisable in equal monthly installments, contingent upon continued service to the Company, with the first vesting date on June 4, 2016, which was one month after the date on which the option was granted. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 21:01 UTC |
GILMAN STEVEN CDirector
|
SaleCommon Stock | 7,500 | $18.02 | $135,129.00 |
DisclosureSEC source: 0001593968-19-000610 · primary_01.xml · nonDerivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 21:01 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionCommon Stock | 7,500 | $2.76 | $20,700.00 |
DisclosureSEC source: 0001593968-19-000610 · primary_01.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,692 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001593968-19-000483 · primary_01.xml · derivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,496 Underlying: Common Stock · 8,692 shares Expires 2026-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase a total of 165,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 27,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001593968-19-000483 · primary_01.xml · derivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,452 Underlying: Common Stock · 27,500 shares Expires 2025-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options, representing the right to purchase a total of 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 8,692 | $1.95 | $16,949.40 |
DisclosureSEC source: 0001593968-19-000483 · primary_01.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 19, 2019 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 27,500 | $3.02 | $83,050.00 |
DisclosureSEC source: 0001593968-19-000483 · primary_01.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 21:16 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
SaleCommon Stock | 10,000 | $17.09 | $170,880.00 |
DisclosureSEC source: 0001593968-19-000416 · primary_01.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,249 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2018. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 21:07 UTC |
Orlando DanielChief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-000396 · primary_01.xml · derivative · entry 3 Orlando Daniel · CIK 0001563759 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in four annual installments with 3,500 RSUs vesting on February 6, 2020, February 6, 2021, February 6, 2022, and February 6, 2023, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 21:07 UTC |
Orlando DanielChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 9,303 | $0.00 Strike: $16.66 | $0.00 |
DisclosureSEC source: 0001593968-19-000396 · primary_01.xml · derivative · entry 2 Orlando Daniel · CIK 0001563759 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,303 Underlying: Common Stock · 9,303 shares Expires 2029-02-06 F1 · derivative.exercise_date: These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 21:07 UTC |
Orlando DanielChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 130,697 | $0.00 Strike: $16.66 | $0.00 |
DisclosureSEC source: 0001593968-19-000396 · primary_01.xml · derivative · entry 1 Orlando Daniel · CIK 0001563759 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,697 Underlying: Common Stock · 130,697 shares Expires 2029-02-06 F1 · derivative.exercise_date: These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 21:06 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
GrantRestricted Stock Unit · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-19-000395 · primary_01.xml · derivative · entry 3 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. F3 · derivative.exercise_date: These RSUs vest in four annual installments with 3,000 RSUs vesting on February 6, 2020, February 6, 2021, February 6, 2022, and February 6, 2023, respectively. F4 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 21:06 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
GrantStock Option (right to buy) · Derivative | 113,197 | $0.00 Strike: $16.66 | $0.00 |
DisclosureSEC source: 0001593968-19-000395 · primary_01.xml · derivative · entry 2 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,197 Underlying: Common Stock · 113,197 shares Expires 2029-02-06 F1 · derivative.exercise_date: These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 21:06 UTC |
MICHEL GERARD JCFO and VP, Corp. Development
|
GrantStock Option (right to buy) · Derivative | 9,303 | $0.00 Strike: $16.66 | $0.00 |
DisclosureSEC source: 0001593968-19-000395 · primary_01.xml · derivative · entry 1 MICHEL GERARD J · CIK 0001235644 · CFO and VP, Corp. Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,303 Underlying: Common Stock · 9,303 shares Expires 2029-02-06 F1 · derivative.exercise_date: These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 21:05 UTC |
Colangelo DominickDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 303,998 | $0.00 Strike: $16.66 | $0.00 |
DisclosureSEC source: 0001593968-19-000394 · primary_01.xml · derivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,998 Underlying: Common Stock · 303,998 shares Expires 2029-02-06 F1 · derivative.exercise_date: These options shall begin vesting on February 6, 2019 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.